Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis

Blood

Volumn 100, Issue 13, 2002, Pages 4550-4556

  Ponchel, Frederique ^a,b,c   Morgan, Ann W ^a,b,c   Bingham, Sarah J ^a,b,c   Quinn, Mark ^a,b,c   Buch, Maya ^a,b,c   Verburg, Robert J ^a,b,c   Henwood, Judy ^a,b,c   Douglas, Susan H ^a,b,c   Masurel, Aurelie ^a,b,c   Conaghan, Philip ^a,b,c   Gesinde, Moji ^a,b,c   Taylor, Julia ^a,b,c   Markham, Alexander F ^a,b,c   Emery, Paul ^a,b,c   Van Laar, Jacob M ^a,b,c   Isaacs, John D ^a,b,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SEACROFT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD45 ANTIGEN; PADGEM PROTEIN; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALE; ONTOGENY; PATIENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 0037114690     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-03-0671     Document Type: Article

References (53)

1. Reveille J. The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol. 1998;10:187-200.
2. Williams D. Autoimmunity in Rheumatoid Arthritis. In: Klippel JH. Rheumatology. London, England: Mosby-Year Book Europe; 1998:3.9.1-3.9.14.
3. Fox A. The role of T-cells in the pathogenesis of rheumatoid arthritis: New perspectives. Arthritis Rheum. 1997;40:598-609.
4. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: Passive responders or transformed aggressors? Arthritis Rheum. 1996;39:1781-1790.
5. Ali M, Ponchel F, Wilson KE, et al. Rheumatoid arthritis synovial T-cells regulate transcription of several genes associated with antigen-induced anergy. J Clin Invest. 2001;107:519-528.
6. Allen ME, Young SP, Michell RH, Bacon PA. Altered T-lymphocyte signaling in rheumatoid arthritis. Eur J Immunol. 1995;25:1547-1554.
7. Emery P, Panayl GS, Nouri AME. Interleukin-2 reverses deficient T-cell-mediated immune-responses in rheumatoid arthritis. Clin Exp Immunol. 1984;57:123-129.
8. Pincus T, Callahan LF. The side-effects of rheumatoid arthritis: Joint destruction, disability and early mortality. Br J Rheumatol. 1993;32:28-37.
9. Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37:481-494.
10. Martens PB, Goronzy JJ, Schaid D, Weyand CM. Expansion of unusual CD4+ T-cells in severe rheumatoid arthritis. Arthritis Rheum. 1997;40:1106-1114.
11. Schmidt D, Goronzy JJ, Weyand CM. CD4(+) CD7(-) CD28(-) T-cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest. 1996;97:2027-2037.
12. Wagner UG, Koetz K, Weyand CM, Goronzy JJ. Perturbation of the T-cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A. 1998;95:14447-14452.
13. WalserKuntz DR, Weyand CM, Fulbright JW, Moore SB, Goronzy JJ. HLA-DRB1 molecules and antigenic experience shape the repertoire of CD4 T-cells. Hum Immunol. 1995;44:203-209.
14. Verburg RJ, Kruize AA, van den Hoogen FHJ, et al. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: Results of an open study to assess feasibility, safety, and efficacy. Arthritis Rheum. 2001;44:754-760.
15. Bingham S, Veale D, Fearon U, et al. High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: Short-term efficacy correlates with reduction of macroscopic and histologic synovitis. Arthritis Rheum. 2002;46:837-839.
16. Isaacs JD, Greer S, Sharma S, et al. Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia. Arthritis Rheum. 2001;44:1998-2008.
17. Dumont-Girard F, Roux E, van Lier RA, et al. Reconstitution of the T-cell compartment after bone marrow transplantation: Restoration of the repertoire by thymic emigrants. Blood. 1998;92:4464-4471.
18. Amigo ML, del Canizo MC, Caballero MD, et al. Factors that influence long-term hematopoietic function following autologous stem cell transplantation. Bone Marrow Transplant. 1999;24:289-293.
19. Nachbaur D, Kropshofer G, Heitger A, et al. Phenotypic and functional lymphocyte recovery after CD34(+)-enriched versus non-T-cell-depleted autologous peripheral blood stem cell transplantation. J Hematother Stem Cell Res. 2000;9:727-736.
20. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med. 1995;332:143-149.
21. Takeshita S, Toda M, Yamagishi H. Excision products of the T-cell receptor gene support a progressive rearrangement model of the α/β locus. EMBO J. 1989;8:3261-3270.
22. Haynes B, Markert L, Sempowski G, Patel D, Hale L. The role of the thymus in immune reconstitution in ageing, bone marrow transplantation and HIV infection. Ann Rev Immunol. 2000;18:529-560.
23. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396:690-695.
24. Douek DC, Vescio RA, Betts MR, et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet. 2000;355:1875-1881.
25. Patel DD, Gooding ME, Parrott RE, et al. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 2000;342:1325-1332.
26. Poulin JF, Viswanathan MN, Harris JM, et al. Direct evidence for thymic function in adult humans. J Exp Med. 1999;190:479-486.
27. Hazenberg MD, Otto SA, Stuart J, et al. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T-cell population in HIV-1 infection. Nat Med. 2000;6:1036-1042.
28. Koetz K, Bryl E, Spickschen K, et al. T-cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A. 2000;97:9203-9208.
29. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
30. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708-712.
31. McFarland RD, Douek DC, Koup RA, Picker LJ. Identification of a human recent thymic emigrant phenotype. Proc Natl Acad Sci U S A. 2000;97:4215-4220.
32. Hintzen RQ, Fiszer U, Fredrikson S, et al. Analysis of CD27 surface expression on T-cell subsets in MS patients and control individuals. J Neuroimmunol. 1995;56:99-105.
33. Kim C, Campbell D, Butcher E. Non-polarized memory T-cells. Trends Immunol. 2001;22:527-530.
34. Salmon M, Pilling D, Borthwick N, et al. The progressive differentiation of primed T-cells is assocated with an increased susceptibility to apoptosis. Eur J Immunol. 1994;24:892-899.
35. Arlettaz L, Barbey C, Dumont-Girard F, et al. CD45 isoform phenotypes of human T-cells: CD4(+)CD45RA(-)RO(+) memory T-cells reacquire CD45RA without losing CD45RO. Eur J Immunol. 1999;29:3987-3994.
36. Hall SR, Heffernan BM, Thompson NT, Rowan WC. CD4(+)CD45RA(+) and CD4(+)CD45RO(+) T-cells differ in their TCR-associated signaling responses. Eur J Immunol. 1999;29:2098-2106.
37. Farber DL, Acuto O, Bottomly K. Differential T-cell receptor-mediated signaling in naive and memory CD4 T-cells. Eur J Immunol. 1997;27:2094-2101.
38. Young JL, Ramage JM, Gaston JSH, Beverley PCL. In vitro responses of human CD45RO(bright)RA(-) and CD45RO(-)RA(bright) T-cell subsets and their relationship to memory and naive T-cells. Eur J Immunol. 1997;27:2383-2390.
39. Unutmaz D, Baldoni F, Abrignani S. Human naive T-cells activated by cytokines differentiate into a split phenotype with functional features intermediate between naive and memory T-cells. Int Immunol. 1995;7:1417-1424.
40. Murali-Krisna K, Ahmed R. Naive T-cells masquerading as memory cells. J Immunol. 2000;165:1733-1737.
41. Lightstone L, Marvel J. CD45RA+ T-cells: Not simple virgins. Clin Sci. 1993;85:515-519.
42. Brennan FM, Hayes AL, Ciesielski CJ, et al. Evidence that rheumatoid arthritis synovial T-cells are similar to cytokine-activated T-cells: Involvement of phosphatidylinositol 3-kinase and nuclear factor kappa B pathways in tumor necrosis factor production in rheumatoid arthritis. Arthritis Rheum. 2002;46:31-41.
43. Sebbag M, Parry SL, Brennan FM, Feldmann M. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: Possible relevance to pathophysiology of rheumatoid arthritis. Eur J Immunol. 1997;27:624-632.
44. Martens P, Schmidt D, Schaid D, Weyand C, Goronzy J. CD4+ CD28-T lymphocytes in rheumatoid arthritis (RA). J Invest Med. 1996;44:A297.
45. Imbedi L, Sottini A, Signorini S, Goda R, Primi D. Oligoclonal CD4(+)CD57(+) T-cell expansions contribute to the imbalanced T-cell receptor repertoire of rheumatoid arthritis patients. Blood. 1997;89:2822-2832.
46. Maeda T, Yamada H, Nagamine R, et al. Involvement of CD4+, CD57+ T-cells in the disease activity of rheumatoid arthritis. Arthritis Rheum. 2002;46:379-384.
47. Salmon M, Gaston J. The role of lymphocytes in rheumatoid arthritis. Br Med Bull. 1995;51:332-345.
48. Kraan MC, Versendaal H, Jonker M, et al. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum. 1998;41:1481-1488.
49. Waase I, Kayser C, Carlson PJ, Goronzy JJ, Weyand CM. Oligoclonal T-cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis Rheum. 1996;39:904-913.
50. Baseta J, Stutman O. TNF regulates thymocyte production by apoptosis and proliferation of the triple negative (CD3-CD4-CD8-) subset. J Immunol. 2000;165:5621-5630.
51. Sempowski GD, Hale LP, Sundy JS, et al. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol. 2000;164:2180-2187.
52. Schluns K, Cook J, Le P. TGF-beta differentially modulates epidermal growth factor-mediated increases in leukemia-inhibitory factor, IL-6, IL-1-alpha and IL-1-beta in human thymic epithelial cells. J Immunol. 1997;158:2704-2712.
53. Haynes BF. Human thymic epithelium and T-cell development: Current issues and future directions. Thymus. 1990;16:143-157.